Health Care Planning

The 2024 US Preventive Services Task Force (USPSTF) Recommendation Statement reaffirms the importance of early screening for syphilis infection in all pregnant individuals to prevent congenital syphilis and associated complications. The report underscores timely testing—including repeat screening in high-risk cases—as a critical measure to safeguard maternal and infant health.

This toolkit delivers updated data visualizations, infographics, and social media assets spotlighting the intersection of viral hepatitis and the opioid crisis—highlighting regional opioid prescribing rates alongside Hepatitis C mortality trends to support awareness campaigns during Hepatitis Awareness Month.

This guideline provides comprehensive, evidence-based recommendations on prophylaxis, treatment, immunization, and drug interactions for a wide range of pediatric OIs—including new additions for coccidioidomycosis, hepatitis B revaccination, and updated immunization schedules—to guide clinicians caring for HIV‑exposed and infected children.

This guideline offers updated, evidence-based recommendations—from preconception through postpartum—on universal prenatal HIV testing, preferred antiretroviral regimens (e.g., bictegravir/TAF/FTC), maternal viral monitoring, obstetric management, and neonatal prophylaxis to further reduce perinatal HIV transmission toward elimination goals (defined as <1% transmission rate and <1 infection per 100,000 live births).

This information sheet offers an in-depth analysis of current AFP models—including funding mechanisms, stakeholder roles, and implementation strategies—to support sustainability of HIV-related services beyond traditional grant funding. It outlines key considerations and best practices to help health departments and community partners explore and launch innovative financing options for long-term epidemic response planning.

This toolkit supports Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Programs (ADAPs)—which provide access to HIV-related medications for low-income individuals—in navigating the planning, selection, and implementation of benefits management contracts. It offers key definitions, planning tools, real-world examples, and checklists to help ADAP administrators—new or experienced—align contractor selection with their program’s unique infrastructure and needs.

In this webinar, CDC and HRSA speakers review the calendar year 2027–2031 Integrated HIV Prevention & Care Plan Guidance—highlighting key updates, submission requirements, and real-world recipient examples. The training equips CDC- and HRSA-funded jurisdictions with technical support, planning tools, and strategies to develop coordinated HIV prevention and care efforts by the June 30, 2026 deadline.

This fact sheet addresses common questions about insurance coverage for viral hepatitis prevention and treatment services. It outlines coverage details for hepatitis A and B vaccinations, hepatitis B and C screenings, and treatments across various insurance types, including Medicaid, Medicare, and private plans.

This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine. 

This information sheet explains the requirement for insurers to cover Pre-Exposure Prophylaxis (PrEP) without cost-sharing.